Gender differences in alcohol treatment: an analysis of outcome from the COMBINE study.

Alcoholism, Clinical and Experimental Research
Shelly F GreenfieldC L Randall

Abstract

Relatively few studies have examined gender differences in the effectiveness of specific behavioral or pharmacologic treatment of alcohol dependence. The aim of this study is to assess whether there were gender differences in treatment outcomes for specific behavioral and medication treatments singly or in combination by conducting a secondary analysis of public access data from the national, multisite NIAAA-sponsored COMBINE study. The COMBINE study investigated alcohol treatment among 8 groups of patients (378 women, 848 men) who received medical management (MM) with 16 weeks of placebo, naltrexone (100 mg/day), acamprosate (3 g/day), or their combination with or without a specialist-delivered combined behavioral intervention. We examined efficacy measures separately for men and women, followed by an overall analysis that included gender and its interaction with treatment condition in the analyses. These analyses were performed to confirm whether the findings reported in the parent trial were also relevant to women, and to more closely examine secondary outcome variables that were not analyzed previously for gender effects. Compared to men, women reported a later age of onset of alcohol dependence by approximately 3 years, we...Continue Reading

References

Oct 14, 1992·JAMA : the Journal of the American Medical Association·C Weisner, L Schmidt
Jan 1, 1989·The International Journal of the Addictions·N J PiazzaR D Yeager
Jan 1, 1995·American Journal of Public Health·C WeisnerR Room
Jan 1, 1996·Journal of Substance Abuse·D A Dawson
Mar 24, 1998·Archives of General Psychiatry·S F GreenfieldJ Michael
Mar 26, 1999·Journal of Studies on Alcohol·C L RandallM E Mattson
Jan 27, 2000·The Journal of Trauma·L M GentilelloR R Ries
Aug 22, 2002·Drug and Alcohol Review·Ann M Roche, Ann Deehan
Jul 25, 2003·Alcoholism, Clinical and Experimental Research·UNKNOWN COMBINE Study Research Group
Sep 11, 2003·Alcoholism, Clinical and Experimental Research·Shelly F GreenfieldRoger D Weiss
Apr 6, 2004·Journal of Substance Abuse Treatment·Keith HumphreysRoger Weiss
May 11, 2004·Journal of Addictive Diseases·Carla A GreenMarjorie D Bennett
Sep 17, 2004·The American Journal on Addictions·Helen M PettinatiCraig Lipkin
May 7, 2005·Journal of Clinical Psychopharmacology·Daphne Simeon, Margaret Knutelska
May 18, 2005·Alcoholism, Clinical and Experimental Research·K MannA Diehl
May 4, 2006·JAMA : the Journal of the American Medical Association·Raymond F AntonUNKNOWN COMBINE Study Research Group
Jun 9, 2006·Drug and Alcohol Dependence·Shelly F GreenfieldGloria M Miele
Aug 1, 2007·Journal of Substance Abuse Treatment·Helen M PettinatiCharles P O'Brien
Nov 6, 2007·Drug and Alcohol Dependence·Katherine M KeyesDeborah S Hasin
Mar 14, 2008·Alcoholism, Clinical and Experimental Research·Richard A GruczaLaura J Bierut
Mar 14, 2008·Alcoholism, Clinical and Experimental Research·A M BarosR F Anton
Nov 27, 2008·The American Journal on Addictions·Jesse J SuhCharles P O'Brien

❮ Previous
Next ❯

Citations

Jul 25, 2013·CNS Drugs·Mark J Niciu, Albert J Arias
Apr 2, 2013·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Annika Thorsell
Jun 10, 2011·Expert Opinion on Investigational Drugs·Thomas HillemacherHelge Frieling
Feb 24, 2016·Frontiers in Psychiatry·Marilyn E Carroll, John R Smethells
May 23, 2014·Obstetrics and Gynecology Clinics of North America·R Kathryn McHughShelly F Greenfield
Jun 4, 2013·Journal of Substance Abuse Treatment·Nikki R WootenMary Jo Larson
Aug 13, 2013·Alcoholism, Clinical and Experimental Research·Ben Lewis, Sara Jo Nixon
Oct 16, 2013·Alcoholism, Clinical and Experimental Research·Rajiv G AgrawalSusan E Bergeson
Jan 28, 2015·Alcoholism, Clinical and Experimental Research·Matthew J WorleyRichard Longabaugh
May 19, 2016·Journal of Addictive Diseases·Diane M HerbeckDesirée Crèvecoeur-MacPhail
Mar 2, 2017·Alcoholism, Clinical and Experimental Research·Shantrel S CanidateRobert L Cook
Mar 30, 2017·Pharmacology, Biochemistry, and Behavior·Patrick A RandallJoyce Besheer
May 26, 2012·Journal of Psychopharmacology·A R Lingford-HughesUNKNOWN British Association for Psychopharmacology, Expert Reviewers Group
Sep 7, 2018·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Aishwarya VijayEvan D Morris
Mar 1, 2019·Alcoholism, Clinical and Experimental Research·Krysten W BoldStephanie S O'Malley
Feb 6, 2020·International Journal of Environmental Research and Public Health·Andreea C BrabeteJulie Stinson
Apr 18, 2020·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Elizabeth M DoncheckJohn R Mantsch
May 15, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Geetanjali ChanderMary E McCaul
Aug 6, 2020·Journal of General Internal Medicine·Haiden A HuskampAlisa B Busch
Jun 28, 2016·Addiction Biology·Marilyn E Carroll, Wendy J Lynch
Apr 6, 2016·Clinical Neuropharmacology·Gihyun YoonJoseph Westermeyer
Sep 30, 2017·Therapeutic Advances in Psychopharmacology·Martyna Sawicka, Derek K Tracy
Feb 23, 2021·Current Addiction Reports·Francina FonsecaMarta Torrens
Apr 3, 2018·Journal of Substance Abuse Treatment·Elizabeth E EpsteinMark D Litt
Mar 15, 2021·Mayo Clinic Proceedings·Camille A KezerVijay H Shah
Apr 10, 2021·Frontiers in Psychiatry·Heinz GrunzeUlrich W Preuss
Nov 28, 2017·Clinical Psychology Review·R Kathryn McHughShelly F Greenfield
Apr 30, 2021·Drug and Alcohol Dependence·Guangfei LiChiang-Shan R Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.